Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Siegenthaler

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|August 29, 2024
[Pharmacotherapy in obesity]Martin Siegenthaler, Knut Mai
International Journal of Cardiology|March 17, 2018
Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-upAlbina Nowak, Martin Siegenthaler, Mehdi Namdar, et al.
Kidney & Blood Pressure Research|March 3, 2017
Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry DiseaseAlbina Nowak, Gilbert Koch, Uyen Huynh-Do, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|August 29, 2024
[Pharmacotherapy in obesity]Martin Siegenthaler, Knut Mai
International Journal of Cardiology|March 17, 2018
Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-upAlbina Nowak, Martin Siegenthaler, Mehdi Namdar, et al.
Kidney & Blood Pressure Research|March 3, 2017
Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry DiseaseAlbina Nowak, Gilbert Koch, Uyen Huynh-Do, et al.
Pageof 1